Patent · US Active

Deuterated analogs of MK2 inhibitors and uses thereof

US11230551B2 · kind B2 · utility

5Cited by
9References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2018
Grant dateJan 25, 2022
Priority date—
Expiry dateMar 15, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.